Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives
June 17, 2013 6:24 am
While the development of antibacterial resistance has broad implications, in gastroenterology patients specific problems have emerged with Helicobacter pylori (H pylori) and this has led to changes in first-line therapy( ). More data on the treatment resistant H pylori has been published (JPGN 2013; 56: 645-48).
77 consecutive strains of H pylori from Brazilian children and adolescents were isolated from gastric biopsies and analyzed; this study took place between 2008-2009 and the mean age was 11.1 years. In 71 strains, there were no previous attempts at eradication.
Results:
Take-home point: Resistance to antibiotics is altering our approach to H pylori therapy. Antibiotic susceptibility testing may be needed to improve antibiotic selection and eradication rates.
Related blog links:
Posted by gutsandgrowth
Categories: Pediatric Gastroenterology Intestinal Disorder
Tags: amoxicillin, antibiotic resistance, clarithromycin, Helicobacter pylori, metronidazole, tetracycline
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
[…] High Rates of Helicobacter Pylori Resistance | gutsandgrowth […]
By What is Evidence-Based Medicine for Helicobacter Pylori? | gutsandgrowth on February 26, 2014 at 7:06 am
[…] High Rates of Helicobacter Pylori Resistance | gutsandgrowth […]
By Understanding Resistance to Helicobacter pylori | gutsandgrowth on September 9, 2014 at 7:01 am
[…] High Rates of Helicobacter Pylori Resistance | gutsandgrowth […]
By Salvage Therapy and Standard Therapy for H pylori | gutsandgrowth on January 21, 2016 at 7:12 am
[…] High Rates of Helicobacter Pylori Resistance | gutsandgrowth […]
By Quadruple Therapy for Helicobacter Pylori Favored in Toronto Guidelines | gutsandgrowth on July 27, 2016 at 7:02 am
[…] High Rates of Helicobacter Pylori Resistance | gutsandgrowth […]
By ACG Guideline for Helicobacter Pylori | gutsandgrowth on February 11, 2017 at 9:11 am